Higher interest rates are likely to keep Wall Street on edge, while Japanese markets are likely to keep the whole world on edge.
Mad Money host Jim Cramer shares his final thoughts of the day.
Cramer can’t help but notice the surprising divergence between Brent and almost every other commodity.
BioMarin CEO JJ Bienaime discusses competition with AstraZeneca and the company's presentation at the ASCO conference.
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.
"Two things usually send a stock higher: takeovers and breakups,” Cramer said. “This stock has the potential for both.”
Agilent is both a stock with both takeover and breakup prospects, says Mad Money host Jim Cramer. "This stock is worth buying here," he adds.
What are we going to do with all of the new found natural gas that we have in this country, mused Cramer.
Cheniere Energy CEO Charif Souki discusses Washington's role in the future of natural gas exploration, and the state of his business.
“The price action is confounding more people than I have seen in some time,” said Cramer. What's going on?
Mad Money host and former hedge fund manager, Jim Cramer, provides stock traders with all manner of investing advice.
Mad Money host Jim Cramer dissects Monday's market action, and the latest headlines out of the ASCO conference.
The Fast Money traders share their final trades of the day.
"Fast Money's" Karen Finerman spoke to OneKingsLane CEO Susan Feldman about her company, and what is something women do well in business.
FBR has upgraded Intel to outperform. The "Fast Money" traders discuss the bull and the bear case for the stock.
Marriott International CEO Arne Sorenson discusses whether he is less concerned about the sequester. "About a billion dollars will be returned to shareholders this year," he says.
Big pharmaceutical stocks are on the move today amid the annual ASCO conference, says CNBC's Barbara Ryan.
Bristol-Myers reached a new 52-week high in today's trading, with the "Fast Money" traders; and David Magee, Suntrust Robinson Humphrey discusses the big boost for Best Buy's stock.
Check out which companies are making headlines after the bell Monday:
The Fast Money traders take a look at today's biggest market movers.